BCRX - Company ID 0000882796
The table below shows BIOCRYST PHARMACEUTICALS INC's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $89.74M | $104.71M | $110.64M | $304.77M | $504.39M | $272.13M |
| Short-term investments | $185.01M | - | - | - | - | - |
| Receivables | $106.82M | $79.07M | $56.95M | $50.60M | $29.41M | $8.65M |
| Inventory | $5.40M | $31.27M | $28.68M | $27.53M | $15.79M | $7.04M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $404.35M |
| $421.97M |
| $495.97M |
| $516.50M |
| $566.14M |
| $323.80M |
| Property, plant & equipment | $8.78M | $7.78M | $7.91M | $8.62M | $8.71M | $7.11M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $514.16M | $490.42M | $516.96M | $550.00M | $588.15M | $334.71M |
| Accounts payable | $15.83M | $11.64M | $20.89M | $14.36M | $27.81M | $18.71M |
| Total current liabilities | $196.07M | $160.38M | $149.99M | $105.51M | $103.72M | $105.65M |
| Long-term debt | $0.00 | $314.87M | $303.23M | $231.62M | $136.08M | $119.73M |
| Total liabilities | $633.31M | $966.35M | - | - | - | - |
| Retained earnings | -$1.51B | -$1.77B | -$1.68B | -$1.45B | -$1.21B | -$1.02B |
| Total equity | -$119.15M | -$475.93M | -$455.53M | -$294.60M | -$106.99M | -$19.26M |